| Implications of glial nitric oxide in neurodegenerative diseases JE Yuste, E Tarragon, CM Campuzano, F Ros-Bernal Frontiers in cellular neuroscience 9, 322, 2015 | 388 | 2015 |
| Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae M Domenech, E Ramos-Sevillano, E García, M Moscoso, J Yuste Infection and immunity 81 (7), 2606-2615, 2013 | 201 | 2013 |
| ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo C Barcia, CM Ros, V Annese, MA Carrillo-de Sauvage, F Ros-Bernal, ... Scientific reports 2 (1), 809, 2012 | 163 | 2012 |
| Streptococcus pneumoniae Resistance to Complement-Mediated Immunity Is Dependent on the Capsular Serotype C Hyams, J Yuste, K Bax, E Camberlein, JN Weiser, JS Brown Infection and immunity 78 (2), 716-725, 2010 | 161 | 2010 |
| Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia J Yuste, M Botto, JC Paton, DW Holden, JS Brown The Journal of Immunology 175 (3), 1813-1819, 2005 | 150 | 2005 |
| Impaired Opsonization with C3b and Phagocytosis of Streptococcus pneumoniae in Sera from Subjects with Defects in the Classical Complement Pathway J Yuste, A Sen, L Truedsson, G Jönsson, LS Tay, C Hyams, ... Infection and immunity 76 (8), 3761-3770, 2008 | 141 | 2008 |
| Screening of Streptococcus pneumoniae ABC Transporter Mutants Demonstrates that LivJHMGF, a Branched-Chain Amino Acid ABC Transporter, Is Necessary for … S Basavanna, S Khandavilli, J Yuste, JM Cohen, AHF Hosie, AJ Webb, ... Infection and immunity 77 (8), 3412-3423, 2009 | 124 | 2009 |
| Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae J Yuste, M Botto, SE Bottoms, JS Brown PLoS Pathogens 3 (9), e120, 2007 | 122 | 2007 |
| Nationwide trends of invasive pneumococcal disease in Spain from 2009 through 2019 in children and adults during the pneumococcal conjugate vaccine era S de Miguel, M Domenech, F González-Camacho, J Sempere, D Vicioso, ... Clinical Infectious Diseases 73 (11), e3778-e3787, 2021 | 106 | 2021 |
| Streptococcus pneumoniae in children in Spain: 1990–1999 A Fenoll, I Jado, D Vicioso, S Berron, JE Yuste, J Casal Acta Paediatrica 89, 44-50, 2000 | 106 | 2000 |
| Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease HE Baxendale, M Johnson, RCM Stephens, J Yuste, N Klein, JS Brown, ... Clinical & Experimental Immunology 151 (1), 51-60, 2008 | 100 | 2008 |
| Antibodies to the Iron Uptake ABC Transporter Lipoproteins PiaA and PiuA Promote Opsonophagocytosis of Streptococcus pneumoniae M Jomaa, J Yuste, JC Paton, C Jones, G Dougan, JS Brown Infection and immunity 73 (10), 6852-6859, 2005 | 97 | 2005 |
| Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae E Ramos-Sevillano, M Moscoso, P García, E García, J Yuste PloS one 6 (8), e23626, 2011 | 94 | 2011 |
| New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia R Tarancón, J Domínguez-Andrés, S Uranga, AV Ferreira, LA Groh, ... PLoS pathogens 16 (4), e1008404, 2020 | 93 | 2020 |
| Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus P Letrado, B Corsini, R Díez-Martínez, N Bustamante, JE Yuste, P García Future Microbiology 13 (11), 1215-1223, 2018 | 83 | 2018 |
| Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS … D Shaw, R Abad, Z Amin-Chowdhury, A Bautista, D Bennett, K Broughton, ... The Lancet Digital Health 5 (9), e582-e593, 2023 | 82 | 2023 |
| Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence S Khandavilli, KA Homer, J Yuste, S Basavanna, T Mitchell, JS Brown Molecular microbiology 67 (3), 541-557, 2008 | 82 | 2008 |
| Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections L Aguinagalde, R Diez-Martinez, J Yuste, I Royo, C Gil, Í Lasa, ... Journal of Antimicrobial Chemotherapy 70 (9), 2608-2617, 2015 | 77 | 2015 |
| The effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulence S Basavanna, S Chimalapati, A Maqbool, B Rubbo, J Yuste, RJ Wilson, ... PLoS One 8 (1), e49638, 2013 | 76 | 2013 |
| Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response E Ramos-Sevillano, A Urzainqui, S Campuzano, M Moscoso, ... Infection and immunity 83 (2), 591-603, 2015 | 70 | 2015 |
